Immediate Impact
12 from Science/Nature 59 standout
Citing Papers
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Works of Michael Fennessy being referenced
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
2017
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael Fennessy | 173 | 109 | 160 | 8 | 322 | |
| Homayoun Shahidi | 53 | 49 | 181 | 8 | 316 | |
| Gaffey Mj | 147 | 20 | 181 | 11 | 299 | |
| L Pan | 245 | 10 | 148 | 8 | 367 | |
| Frédéric Desmoulins | 48 | 73 | 57 | 6 | 331 | |
| E. Swisher | 93 | 84 | 115 | 9 | 364 | |
| Agnes Keh-Yen | 58 | 23 | 61 | 8 | 341 | |
| Cecilia Dalle Ore | 69 | 25 | 72 | 14 | 292 | |
| Papac Rj | 38 | 37 | 137 | 9 | 335 | |
| Jacques‐Eric Gottenberg | 38 | 59 | 35 | 9 | 323 | |
| Amy Lloyd | 133 | 67 | 70 | 12 | 317 |
All Works
Loading papers...